InsidersTradesSigma
Follow the 蓝帆医疗 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 蓝帆医疗 has logged 5 public disclosures. Market capitalisation: €5.9bn. The latest transaction was disclosed on 20 March 2026 (Purchase). Among the most active insiders: 于苏华. All data is free.
5
Insider Decl.
n/a
Thresholds
€681,912
3 ops.
Buy Volume
€1,929
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,468 of 28,803 companies
19.8
score / 100
Value23
Quality16
FCF yld-1.6%
Earn yld-13%
EV/EBITDA·
ROE-8.8%
Gross mgn16%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 March 2026
Declarations5 total
5 of 5 declarations
About 蓝帆医疗
蓝帆医疗 is a company focused on the healthcare and pharmaceutical sector, providing medical products and healthcare solutions. It is listed on the XSHE market.